Document Detail

Endothelaemia--a marker of vascular damage.
MedLine Citation:
PMID:  18225478     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of the study was to determine the amount of circulating endothelial cells (CECs) in patients with an advanced cardiovascular (CV) disease, compare the values with a control group and finally to ascertain if there are statistically significant differences within the studied patient groups. BACKGROUND: Endothelaemia has been intensively studied as a marker of vascular injury. Clinical studies have demonstrated an increased endothelaemia in patients at high CV risk but also in certain non-cardiovascular disorders. Its possible usage in the diagnostics of the acute coronary syndrome and for CV risk assessment needs further investigations. METHODS: Thirty six hospitalized patients were studied. Quantitative measurement of endothelaemia was performed by the method developed by J. Hladovec. It is based on ECs counting in Bürker's chamber after their isolation with platelets and the removal of the latter by an addition of adenosine-diphosphate. RESULTS: The mean baseline endothelaemia was significantly higher in patients with increased cardiovascular risk when compared with the control group (1.38 +/- 0.899): ACS (4.9 +/- 1.59, p < 0.05) and PAOD (3.74 +/- 0.61, p < 0.05). When comparing the mean endothelaemia values in patients with PAOD before (2.67 +/- 0.86) and after (3.88 +/- 0.77) surgery, a significant increase of endothelaemia was observed (p < 0.05). CONCLUSION: Our pilot study, though limited by a relatively small number of patients, proved a significant increase of endothelaemia in patients at high CV risk, which is consistent with other available data. The introduction of newer specific methods based on immunomagnetic principles may provide a wider use of endothelaemia measurement in clinical settings (Fig. 3, Ref. 17). Full Text (Free, PDF)
J Rajec; J Tisonova; M Kriska; V Kristova; R Vojtko; A Dukat; E Ambrozy; R Slysko; I Varga
Related Documents :
18665658 - Secondary prevention of coronary heart disease in elderly patients following myocardial...
10676718 - Ace gene polymorphism and survival in atherosclerotic renovascular disease.
17374088 - Vascular calcification and disordered mineral metabolism in dialysis patients.
11886478 - Preventing atherothrombotic events in peripheral arterial disease: the use of antiplate...
10092698 - Pseudo-steroid resistant asthma.
11129938 - Bedrest after elective cardiac catheterisation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Bratislavské lekárske listy     Volume:  108     ISSN:  0006-9248     ISO Abbreviation:  Bratisl Lek Listy     Publication Date:  2007  
Date Detail:
Created Date:  2008-01-29     Completed Date:  2008-04-01     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0065324     Medline TA:  Bratisl Lek Listy     Country:  Slovakia    
Other Details:
Languages:  eng     Pagination:  403-5     Citation Subset:  IM    
Department of Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Biological Markers / blood
Cardiovascular Diseases / blood*,  diagnosis*
Endothelium, Vascular*
Middle Aged
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antibodies to Borrelia burgdorferi in erythema migrans patients.
Next Document:  Evaluation and treatment of hip joint instability in patients with cerebral palsy.